MBI_Logo_Tagline_Blue.jpg
Meridian Launches Two New Air-Dryable qPCR Mixes Enabling Direct Detection of DNA or RNA from Stool Samples
September 09, 2021 10:00 ET | Meridian Bioscience Inc.
CINCINNATI, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today the addition of...
MBI_Logo_Tagline_Blue.jpg
Meridian Launches Two New Air-Dryable qPCR Mixes Enabling Direct Detection of DNA or RNA from Saliva Samples
September 07, 2021 10:00 ET | Meridian Bioscience Inc.
CINCINNATI, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today the launch of its...
MBI_Logo_Tagline_Blue.jpg
Meridian Bioscience Reports Third Quarter Fiscal 2021 Results
August 06, 2021 08:00 ET | Meridian Bioscience Inc.
CINCINNATI, Aug. 06, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the third quarter ended June 30, 2021. Third Quarter 2021 Highlights...
MBI_Logo_Tagline_Blue.jpg
Meridian Closes Acquisition of BreathTek® Business
August 02, 2021 09:00 ET | Meridian Bioscience Inc.
CINCINNATI, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today that it closed the...
MBI_Logo_Tagline_Blue.jpg
Meridian Signs Definitive Agreement to Acquire Urea Breath Test for H. pylori from Otsuka America Pharmaceutical, Inc.
July 23, 2021 09:20 ET | Meridian Bioscience Inc.
CINCINNATI, July 23, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today that it signed a...
MBI_Logo_Tagline_Blue.jpg
Meridian Bioscience to Hold Third Quarter Fiscal 2021 Financial Results Conference Call on August 6, 2021
July 14, 2021 09:00 ET | Meridian Bioscience Inc.
CINCINNATI, July 14, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, will report third quarter fiscal...
MBI_Logo_Tagline_Blue.jpg
Meridian Bioscience Announces Preliminary Revenue Results for Fiscal 2021 Third Quarter
July 13, 2021 09:00 ET | Meridian Bioscience Inc.
CINCINNATI, July 13, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, today provided preliminary revenue...
MBI_Logo_Tagline_Blue.jpg
Meridian Resubmits Application to FDA for Emergency Use Authorization for Revogene® SARS-CoV-2 Molecular Assay
June 28, 2021 09:25 ET | Meridian Bioscience Inc.
CINCINNATI, June 28, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today that it has...
MBI_Logo_Tagline_Blue.jpg
Meridian’s New Master Mix for LAMP Assays Offers a Practical Solution for POC Molecular Detection of RNA viruses
June 16, 2021 09:00 ET | Meridian Bioscience Inc.
CINCINNATI, June 16, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today the launch of the...
MBI_Logo_Tagline_Blue.jpg
Meridian Bioscience to Participate in the 41st Annual William Blair Growth Stock Conference and Jefferies Virtual Healthcare Conference
May 27, 2021 10:00 ET | Meridian Bioscience Inc.
CINCINNATI, May 27, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) announced today participation in two upcoming investor conferences. Jack Kenny, Chief Executive Officer, will...